Articles tagged with Blood Glucose
A randomized controlled trial shows that low-dose hydrocortisone continuous infusion minimizes hyperglycaemic episodes and serious adverse events in critically ill patients with sepsis. Continuous infusion also reduces nurses' workload by requiring fewer insulin dose adjustments.
A new study aims to improve diabetes management by linking patients' glucose levels to their pharmacists. Half of the participants will share their data with their pharmacist for lifestyle advice, while the other half will manage it themselves.
A recent study found that high blood glucose is responsible for approximately 2.2 million cardiovascular deaths and 1.5 million ischaemic heart disease deaths worldwide. The findings highlight the significant burden of high blood glucose on mortality from these conditions.
A new study by Joslin Diabetes Center has shown that with proper training and follow-up, over 80% of children and teens can successfully use insulin pumps to manage type 1 diabetes. The study identified key risk factors for failure, including infrequent blood glucose monitoring and high rates of severe hypoglycemia.
A study of 161 African-Americans with type 2 diabetes found that poor sleep quality and quantity were associated with higher HbA1c levels, indicating poorer blood glucose control. The results suggest that optimizing sleep duration and quality may improve glucose control in patients with type 2 diabetes.
Researchers at U of T confirm the GI's reliability as a predictor of blood glucose levels, despite concerns over unpredictable outcomes. The study found that 90% of variation was explained by carbohydrate content and GI values, validating the concept's effectiveness in managing blood glucose.
Researchers at Johns Hopkins Medicine have discovered a protein called GCN5 that plays a crucial role in controlling blood sugar levels. By altering the activity of another protein, PGC-1alpha, GCN5 can turn off pathways leading to glucose release from liver cells.
A recent study found that patients with diabetes who take an antidepressant medication after recovering from depression experience significantly lower rates of depression and better blood glucose control. The study, published in Archives of General Psychiatry, suggests that controlling depression can help manage blood sugar levels.
Researchers found that both self-monitoring of blood glucose and precise physician testing of hemoglobin A1c can help diabetics manage their disease. Consistent communication between patients and healthcare professionals is also crucial.
A Columbia University study shows that aprotinin decreases blood glucose levels and insulin resistance in diabetic patients undergoing CABG surgery, reducing the risk of complications. The study's findings have important implications for the management of blood glucose levels during heart surgery.
A new study shows that ACTOS significantly improved components of diabetic dyslipidemia compared to Avandia. The results indicate that treatment with ACTOS lowered triglycerides and increased HDL-C, while improving LDL-C particle concentration and size. This is important for reducing cardiovascular risk in patients with type 2 diabetes.
A study found that Salacia oblonga, a herb native to India and Sri Lanka, decreases insulin and blood glucose levels when consumed with meals. The herb works by binding to intestinal enzymes that break down carbohydrates, reducing the amount of glucose in the bloodstream.
A study by Joslin Diabetes Center found that youth ages 8-18 with type 1 diabetes were more likely to monitor their blood glucose levels when playing a guessing game on a wireless-equipped personal digital assistant. The study showed an increase in diabetes knowledge and fewer episodes of hyperglycemia among participants.
The INITIATE study found that NovoLog Mix 70/30 achieved better A1C levels and improved post-mealtime glucose control than insulin glargine. This suggests a physiological approach to controlling insulin needs, which may encourage clinicians to adopt this treatment option.
A new study found that insulin detemir significantly reduces day-to-day variability in blood glucose levels and nighttime hypoglycemia risk compared to NPH. Insulin detemir also leads to less weight gain in patients with type 1 diabetes.
A study highlights the significant risk of cardiovascular disease in women with type 2 diabetes, emphasizing the importance of controlling blood glucose levels, managing cholesterol, and preventing diabetes. The researchers outline strategies for treating diabetic women and CVD, including intensive therapy and lifestyle modifications.
A team of researchers developed an optical glucose sensor that functions as a continuous glucose monitor capable of operating under physiological conditions. The sensor shows outstanding glucose response over the full range of glucose levels, which could reduce pain, costs, and deaths in ICU patients.
Researchers found that buckwheat extract can reduce blood glucose concentrations in rats with chemically-induced diabetes by 12-19%, suggesting its potential as a management aid. The active component chiro-inositol may play a role in this effect, although further studies are needed to confirm the results.
Researchers review new glucose monitoring technologies, including non-invasive options that could lead to better compliance with testing recommendations. Continuous glucose monitoring systems also hold promise for early detection of hidden glucose trends.
Hebrew University scientists have created a new type of enzyme electrode that uses gold nanoparticles to detect glucose in the blood. This technology offers more sensitive and specific measurements than existing techniques, with potential applications for diabetes treatment and implantable biofuel cells.
A study by Ohio State University found that some energy bars give a sudden spike in blood sugar levels, unlike the moderate increase claimed for endurance athletes. The Ironman PR Bar had a steady effect due to its balanced carbohydrate and protein content.
The American Association of Cereal Chemists' (AACC) 82nd Annual Meeting will take place in San Diego from October 12-16, featuring a technical program with topics such as blood glucose control, cereal carbohydrates, and sensory evaluation. Over 230 exhibitors will showcase the latest equipment and services.